Cost-Effectiveness Analysis of Intracameral Cefuroxime Use for Prophylaxis of Endophthalmitis after Cataract Surgery

Ophthalmology

Volumn 116, Issue 10, 2009, Pages

  Sharifi, Emile ^a   Porco, Travis C ^a,b   Naseri, Ayman ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFUROXIME; CIPROFLOXACIN; GATIFLOXACIN; GENTAMICIN; MOXIFLOXACIN; OFLOXACIN; POLYMYXIN; SULFACETAMIDE; TRIMETHOPRIM;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CATARACT; CATARACT EXTRACTION; COST EFFECTIVENESS ANALYSIS; ENDOPHTHALMITIS; HUMAN; MODEL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ANTERIOR CHAMBER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CATARACT EXTRACTION; CEFUROXIME; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DRUG COSTS; ENDOPHTHALMITIS; HUMANS; POSTOPERATIVE COMPLICATIONS; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME;

EID: 70349469839     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.03.014     Document Type: Article

References (57)

1. West E.S., Behrens A., McDonnell P.J., et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology 112 (2005) 1388-1394
2. Taban M., Behrens A., Newcomb R.L., et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol 123 (2005) 613-620
3. Herretes S., Stark W.J., Pirouzmanesh A., et al. Inflow of ocular surface fluid into the anterior chamber after phacoemulsification through sutureless corneal cataract wounds. Am J Ophthalmol 140 (2005) 737-740
4. McDonnell P.J., Taban M., Sarayba M., et al. Dynamic morphology of clear corneal cataract incisions. Ophthalmology 110 (2003) 2342-2348
5. Nagaki Y., Hayasaka S., Kadoi C., et al. Bacterial endophthalmitis after small-incision cataract surgery: effect of incision placement and intraocular lens type. J Cataract Refract Surg 29 (2003) 20-26
6. Sarayba M.A., Taban M., Ignacio T.S., et al. Inflow of ocular surface fluid through clear corneal cataract incisions: a laboratory model. Am J Ophthalmol 138 (2004) 206-210
7. ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33 (2007) 978-988
8. Garat M., Moser C.L., Alonso-Tarres C., et al. Intracameral cefazolin to prevent endophthalmitis in cataract surgery: 3-year retrospective study [letter]. J Cataract Refract Surg 31 (2005) 2230-2234
9. Lundstrom M., Wejde G., Stenevi U., et al. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 114 (2007) 866-870
10. Miller J.J., Scott I.U., Flynn Jr. H.W., et al. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 139 (2005) 983-987
11. Mollan S.P., Gao A., Lockwood A., et al. Postcataract endophthalmitis: incidence and microbial isolates in a United Kingdom region from 1996 through 2004. J Cataract Refract Surg 33 (2007) 265-268
12. Montan P.G., Wejde G., Koranyi G., and Rylander M. Prophylactic intracameral cefuroxime: efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 28 (2002) 977-981
13. Ng J.Q., Morlet N., Bulsara M.K., and Semmens J.B. Reducing the risk for endophthalmitis after cataract surgery: population-based nested case-control study: Endophthalmitis Population Study of Western Australia sixth report. J Cataract Refract Surg 33 (2007) 269
14. Romero P., Mendez I., Salvat M., et al. Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery. J Cataract Refract Surg 32 (2006) 438-441
15. Gimbel H.V., Sun R., and DeBrof B.M. Prophylactic intracameral antibiotics during cataract surgery: the incidence of endophthalmitis and corneal endothelial cell loss. Eur J Implant Refract Surg 6 (1994) 280-285
16. Peyman G.A., Sathar M.L., and May D.R. Intraocular gentamicin as intraoperative prophylaxis in South India eye camps. Br J Ophthalmol 61 (1977) 260-262
17. Chang D.F., Braga-Mele R., Mamalis N., et al., ASCRS Cataract Clinical Committee. Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J Cataract Refract Surg 33 (2007) 1801-1805
18. Colleaux K.M., and Hamilton W.K. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can J Ophthalmol 35 (2000) 373-378
19. McCulley J.P. Low acute endophthalmitis rate: possible explanations [letter]. J Cataract Refract Surg 31 (2005) 1074-1075
20. Moshirfar M., Feiz V., Vitale A.T., et al. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. Ophthalmology 114 (2007) 686-691
21. O'Brien T.P., Arshinoff S.A., and Mah F.S. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Refract Surg 33 (2007) 1790-1800
22. Weinstein M.C., Siegel J.E., Gold M.R., et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276 (1996) 1253-1258
23. Siegel J.E., Weinstein M.C., Russell L.B., Gold M.R., and Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses. JAMA 276 (1996) 1339-1341
24. Gold M. Panel on Cost-Effectiveness in Health and Medicine. Med Care 34 suppl (1996) DS197-DS199
25. Russell L.B., Gold M.R., Siegel J.E., et al., Panel on Cost-Effectiveness in Health and Medicine. The role of cost-effectiveness analysis in health and medicine. JAMA 276 (1996) 1172-1177
26. Mandelblatt J.S., Fryback D.G., Weinstein M.C., et al., Panel on Cost-Effectiveness in Health and Medicine. Assessing the effectiveness of health interventions for cost-effectiveness analysis. J Gen Intern Med 12 (1997) 551-558
27. Busbee B.G., Brown M.M., Brown G.C., and Sharma S. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 109 (2002) 606-612 discussion 612-3
28. Busbee B.G., Brown M.M., Brown G.C., and Sharma S. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology 110 (2003) 2310-2317
29. 2007 Red Book: Pharmacy's Fundamental Reference (2007), Thomson, Montvale, NJ 311 313,330,443,590,625,695,744,760
30. United States Bureau of Labor Statistics. May 2007 National Occupational Employment and Wage Estimates, United States. Healthcare Practitioner and Technical Occupations (29-0000) (2009). http://www.bls.gov/oes/current/oes_nat.htm Last accessed February 27
31. Barnato A.E., Sanders G.D., and Owens D.K. Cost-effectiveness of a potential vaccine for Coccidioides immitis. Emerg Infect Dis 7 (2001) 797-806
32. Chelmow D., Hennesy M., and Evantash E.G. Prophylactic antibiotics for non-laboring patients with intact membranes undergoing cesarean delivery: an economic analysis. Am J Obstet Gynecol 191 (2004) 1661-1665
33. Devereux R.B., Frary C.J., Kramer-Fox R., et al. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. Am J Cardiol 74 (1994) 1024-1029
34. Flabbee J., Petit N., Jay N., et al. The economic costs of severe anaphylaxis in France: an inquiry carried out by the Allergy Vigilance Network. Allergy 63 (2008) 360-365
35. Schmier J.K., Halpern M.T., Covert D.W., et al. Evaluation of Medicare costs of endophthalmitis among patients after cataract surgery. Ophthalmology 114 (2007) 1094-1099
36. Wisniewski S.R., Hammer M.E., Grizzard W.S., et al. An investigation of the hospital charges related to the treatment of endophthalmitis in the Endophthalmitis Vitrectomy Study. Ophthalmology 104 (1997) 739-745
37. Simon J.B. Should all people over the age of 50 have regular fecal occult-blood tests?. Postpone population screening until problems are solved. N Engl J Med 338 (1998) 1151-1152 discussion 1154-5
38. Villada J.R., Vicente U., Javaloy J., and Alio J.L. Severe anaphylactic reaction after intracameral antibiotic administration during cataract surgery. J Cataract Refract Surg 31 (2005) 620-621
39. Mamalis N., Edelhauser H.F., Dawson D.G., et al. Toxic anterior segment syndrome. J Cataract Refract Surg 32 (2006) 324-333
40. Kamalarajah S., Ling R., Silvestri G., et al. Presumed infectious endophthalmitis following cataract surgery in the UK: a case-control study of risk factors. Eye 21 (2007) 580
41. Ball J.L., and Barrett G.D. Prospective randomized controlled trial of the effect of intracameral vancomycin and gentamicin on macular retinal thickness and visual function following cataract surgery. J Cataract Refract Surg 32 (2006) 789-794
42. Montan P.G., Wejde G., Setterquist H., et al. Prophylactic intracameral cefuroxime: evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 28 (2002) 982
43. Espiritu C.R., Caparas V.L., and Bolinao J.G. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg 33 (2007) 63-68
44. Koul S., Philipson A., Philipson B.T., et al. Intraocular levels of cefuroxime in uninflamed rabbit eyes. Acta Ophthalmol (Copenh) 68 (1990) 455-465
45. Lane S.S., Osher R.H., Masket S., and Belani S. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. J Cataract Refract Surg 34 (2008) 1451-1459
46. Murphy C.C., Nicholson S., Quah S.A., et al. Pharmacokinetics of vancomycin following intracameral bolus injection in patients undergoing phacoemulsification cataract surgery. Br J Ophthalmol 91 (2007) 1350-1353
47. Kodjikian L., and Garweg J.G. Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model [letter]. Am J Ophthalmol 141 (2006) 777 author reply 7778
48. Kowalski R.P., Romanowski E.G., Mah F.S., et al. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol 140 (2005) 497-504
49. Moreno E., Macias E., Davila I., et al. Hypersensitivity reactions to cephalosporins. Expert Opin Drug Saf 7 (2008) 295-304
50. Pichichero M.E. Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift. Diagn Microbiol Infect Dis 57 suppl (2007) 13S-18S
51. Novalbos A., Sastre J., Cuesta J., et al. Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins. Clin Exp Allergy 31 (2001) 438-443
52. Pichichero M.E., and Casey J.R. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg 136 (2007) 340-347
53. Hellinger W.C., Hasan S.A., Bacalis L.P., et al. Outbreak of toxic anterior segment syndrome following cataract surgery associated with impurities in autoclave steam moisture. Infect Control Hosp Epidemiol 27 (2006) 294-298
54. Jehan F.S., Mamalis N., Spencer T.S., et al. Postoperative sterile endophthalmitis (TASS) associated with the MemoryLens. J Cataract Refract Surg 26 (2000) 1773-1777
55. Kutty P.K., Forster T.S., Wood-Koob C., et al. Multistate outbreak of toxic anterior segment syndrome, 2005. J Cataract Refract Surg 34 (2008) 585-590
56. Werner L., Sher J.H., Taylor J.R., et al. Toxic anterior segment syndrome and possible association with ointment in the anterior chamber following cataract surgery. J Cataract Refract Surg 32 (2006) 227-235
57. Shepard C.W., Ortega-Sanchez I.R., Scott III R.D., Rosenstein N.E., and ABCs Team. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Pediatrics 115 (2005) 1220-1232